The European Patent Office has granted Nanexa’s PharmaShell® patent

28 April, 2022
- Press Release

Nanexa AB (publ) today announced that the European Patent Office (EPO) has granted the company’s patent application relating to the drug delivery system PharmaShell®. The patent protection covers the manufacturing method of PharmaShell and products produced using the method.

“The route to a granted patent application may be long, and we have put a lot of effort into our discussions with EPO to achieve the strongest possible patent protection. It is with great satisfaction that I can now confirm that the PharmaShell patent is granted in Europe. We have all along been confident in our patent situation, but it is still meaning a lot to get it verified by EPO. With the patent granted we will be in an even more interesting position in discussions with potential partners.”, says David Westberg, CEO of Nanexa.